Objectives: The therapeutic utility of hypoxia-inducible factor-1 (HIF-1) transcriptional regulatory system for ischemic hindlimb has been demonstrated. It is not yet known whether this transcriptional regulatory system can be used as a therapeutic strategy to enhance collateral vessel formation in myocardial tissues, where acute hypoxia occurs due to inadequate perfusion. We aimed to test the hypothesis that exogenous administration of HIF-1a / VP16 could enhance collateral vessel formation in a rat acute myocardial infarction model. Methods: Sprague-Dawley rats received ligation of the proximal left anterior descending coronary artery to induce acute myocardial infarction. Immediately after the ligation, 50 mg total plasmid DNA (control, plasmid encoding human vascular endothelial growth factor (pVEGF ), or pHIF-1a / VP16) was injected into the infarct area at three locations. Results: Reverse transcription-polymerase chain 165 reaction (RT-PCR) showed the presence of HIF-1a and VEGF mRNA in the myocardium, but not in other organs at days 3 and 7. The infarct size significantly decreased from 3764% (control) to 2462% in the VEGF-treated group and 2362% in the HIF-1a / VP16 treated 2 2 group (P,0.05). Capillary density also significantly increased from 550675 / mm (control) to 850675 / mm in the VEGF group and 2 850650 / mm in the HIF-1a / VP16-treated group (P,0.01). Combined therapy with HIF-1a / VP16 and VEGF resulted in higher 2 capillary density (1230650 / mm ) than treatment with either therapy alone. Regional myocardial blood flow was also higher in the treated groups than in the control. Plasma levels of VEGF were also significantly higher in the HIF-1a / VP16 and VEGF-treated group than in the control group. Conclusions: The HIF-1a / VP16 hybrid transcription factor is able to reduce infarct size and enhance neovascularization in an acute ischemic myocardium. The potency of VEGF and HIF-1a / VP16 hybrid as therapeutic angiogenic factors in acute hypoxic myocardium is similar.
Intramyocardial injection of naked DNA encoding HIF-1a / VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat a b a a b
Kou-Gi Shyu , Mei-Ti Wang , Bao-Wei Wang , Chih-Chuna Chang , Jyh-Gang Leu , a 1. Introduction [3, 4] , and diabetic neovascularization [5] . Hypoxia also plays a significant role in regulating angiogenesis and New blood vessel formation has been recognized as an vasoformation during mammalian embryonic development adaptive response to cellular hypoxia [1] . In the case of [6] . VEGF is a protein that is essential for angiogenesis [7] . local hypoxia due to inadequate perfusion (ischemia), Increased expression of VEGF gene in hypoxic cells is angiogenesis is stimulated by the production of vascular mediated in part by increased gene transcription [8] [9] [10] [11] . endothelial growth factor (VEGF), a well-known phenomTranscription of genes encoding erythropoietin, VEGF, and enon in coronary artery disease [2] , tumor angiogenesis glycolytic enzymes is activated in hypoxic cells by a common molecular mechanism [12] . Transcriptional activation of these genes is mediated by the binding of hypoxia-inducible factor 1 (HIF-1) to cis-acting hypoxiawas tightened around the proximal left anterior descending response elements located primarily within 59-flanking coronary artery (before the first branch of diagonal artery). regions of these genes [13] . These observations suggest Positive end-expiratory pressure was applied to fully that activation of HIF-1 may be involved in the regulation inflate the lungs. The muscle layer and skin were closed of vascular growth and cellular metabolism.
separately after plasmid injection, and the animals were HIF-1, a DNA binding complex first identified as a allowed to recover. The experimental protocol was apfactor critical for the inducible activity of the erythroproved by the Shin Kong WHS Memorial Hospital compoietin 39 enhancer [14] , is a key physiological regulator of mittee on animal experiments. gene expression that responds to changes in cellular oxygen tension [15] . HIF-1 is a heterodimeric DNA 2.2. Plasmids complex composed of two basic helix-loop-helix Per-AHR-ARNT-Sim-proteins (HIF-1a and HIF-1b) [16] .
The HIF-1a / VP16 plasmid was generated by Genzyme HIF-1a protein levels, which determine the level of HIF-1 Corporation (Framingham, MA, USA). cDNA fragments DNA-binding and transcriptional activity, increases exof HIF-1a at amino acid (aa) 390 as well as VP16 Cponentially as cellular oxygen concentration is reduced terminal aa 413-490 were assembled into a simple eukary- [17] . Under hypoxic conditions, both HIF-1a protein level otic expression plasmid that uses a CMV promoter to drive and the activity of the HIF-1a transactivation domains HIF-1a expression. Downstream from the HIF-1a cDNA increase [17, 18] . Pugh et al. demonstrated that sequences is a BGH polyadenylation sequence. These fragments from HIF-1a but not HIF-1b convey hypoxia-inducible occur in the pUC19 vector, which includes an SV40-neo activity when fused to the DNA binding domain of gene for neomycin resistance. The plasmid pCMVb encodheterologous transcription factors [19] . The HIF-1 gene ing b-galactosidase under control of CMV promoter / enhas been shown to be involved in tumor angiogenesis and hancer was used for the control transfection experiments. growth [20] [21] [22] . The therapeutic utility of this transcripPlasmids were purified with QIAGEN kits. Ethanol pretional regulatory system for targeting gene expression at cipitation was used to sterilize all plasmids in preparation hypoxic tumor cells or ischemic hindlimb has been demonfor myocardial injection, after which, the DNA pellets strated [22, 23] . However, it is not known whether this were reconstituted with sterile PBS containing 5% sucrose, transcriptional regulatory system can be used as a theraand stored at 220 8C. Prior to injection, DNA concenpeutic strategy to enhance collateral vessel formation in trations were determined by a spectrophotometer. The myocardial tissues where acute hypoxia occurs due to plasmid constructs phVEGF and pCMVb have been 165 inadequate perfusion. previously described [25] . The HIF-1a / VP16 hybrid is a constitutively active and more potent form of HIF-1a by constructing a hybrid 2.3. Intramyocardial gene transfer transcription factor consisting of the DNA-binding and dimerization domains from HIF-1a and the transactivation After ligation of the left anterior descending coronary domain from herpes simplex virus VP16 protein [24] . The artery, 50 mg of total plasmid DNA in 0.1 ml of normal HIF-1a / VP16 hybrid up-regulates exogenous VEGF exsaline were injected intramuscularly at the left anterior free pression in vitro and enhances angiogenesis in rabbit wall by using an insulin syringe with a 30-gauge needle. hindlimb ischemia [23] .
After the left ventricle was accessed, the needle was Accordingly, we ought to test the hypothesis that advanced along the left ventricular free wall and plasmid exogenous administration of HIF-1a / VP16 hybrid could DNA was injected over a period of 5 to 10 s at three enhance collateral vessel formation in a rat acute myocarseparate sites. The injected sites were chosen at least 5 mm dial infarction model and to compare the potency of away from the left ventricular apex. All animals received HIF-1a / VP16 hybrid to that of VEGF as a therapeutic three intramyocardial injections of plasmid, with the angiogenic factor. control plasmid being pCMVb. In the treated animals, pHIF-1a / VP16 or phVEGF was injected. After injec-165 tion, the chest was closed and the animals were allowed to 2. Methods recover.
Production of acute myocardial infarction 2.4. b-Galactosidase gene expression
Male Sprague-Dawley rats weighing 250-350 g were To localize the areas of injection and reporter gene intraperitoneally anesthetized with sodium pentobarbital expressions relative to the infarcts, b-galactosidase activity (45 mg / kg). The rats were intubated and ventilated with a was assessed by incubating muscles in 5-bromo-chloro-3-volume-cycled small-animal ventilator. An anterior indolyl-b-D-galactosidase chromogen (X-Gal, Sigma, St. thoracotomy was performed to open the pericardium. The Louis, MO, USA) overnight at 37 8C after intramyocardial heart was then rapidly exteriorized, and a 6-0 silk suture injection of pCMVb in four additional rats. After staining, the muscles were rinsed in saline, post-fixed in 1% septum were separated and weighed. The tissues were then paraformaldehyde, and were then paraffin embedded, immersed and fixed in 10% buffered formalin. Each heart sectioned, and counterstained with hematoxylin and eosin. was sliced in cross section at four levels spanning from the Five sections from each sample were randomly selected, apex to the base and prepared for routine histology. These and the numbers of positive and total myocytes in five sections from each level were stained with 1% trihigh-power fields among an area including pericardium phenyltrtrazolium chloride (TTC) for 20 min. The hiswere counted manually for each specimen.
tological sections of all four slices were projected on a digitalization screen. A planimeter was used to obtain the length of the entire endocardial circumference and that 2.5. Human VEGF and HIF-1 gene expression in segment of the endocardial circumference made up by the ischemic myocardial muscles infarcted portion from each of the four slices of the left ventricle. The infarct size, expressed as a percentage of the Gene expression was evaluated by detecting mRNA left ventricle, was calculated by dividing the circumference levels using RT-PCR with rats of myocardial infarction of the infarct by the total circumference of the left that were put to death at days 1, 3, 7, 14 and 28 after the ventricle including the septum. The person who measured transfection with phVEGF and HIF-1a / VP16 hybrid 165 the infarct size was unaware of the treatment group. (n52 at each time point) or control plasmid (n52 at 7 days after transfection). In the eight rats killed at 3 and 7 days after transfection, remote tissues (lung, liver, spleen, 2.7. Capillary density by immunohistochemistry and aorta) were also retrieved for analysis of human VEGF and HIF-1a mRNA. To ensure specificity and avoid At the day of sacrifice (days 14 and 28 after transfection, amplification of endogenous rat VEGF and HIF-1, each respectively), the left ventricle was harvested, fixed in primer was selected from a region that was not conserved methanol, and sliced into 5 mm paraffin sections. To block among different species. Sequences of primers used for endogenous peroxide activity and nonspecific binding, VEGF were 59-GAGGGCAGAATCATCACGAAGT-39 sections were incubated with 3% hydrogen peroxide (sense) and 59-TGAGAGATCTGGTTCCCGAAAC-39 followed by 10% normal horse serum. Specimens were (antisense). Sequences of primers used for HIF-1a were incubated with a monoclonal anti-mouse CD31 antibody at 59-AGAAAAAGATAAGTTCTGAACGTC-39 (sense) and 4 8C overnight. Bound primary antibodies were detected 59-GAGAAAAAAGCTTCGCTGTGTG-39 (antisense). with the avidin-biotin-immunoperoxidase method (Sig-RT-PCR was performed according to the manufacture's net). Nonimmune normal rabbit IgG was used to confirm protocol (Access RT-PCR System, Promega, Madison, specificity. The number of capillaries was counted in WI, USA). The size of the PCR product for VEGF and regions with transversely sectioned myocytes in the border HIF-1a was 531 and 478 bp, respectively. RT-PCR zone and in the area of infarction. Twenty sections per products were analyzed by 2% agarose gel electrophoresis.
heart were evaluated to estimate capillarity by another To detect the endogenous gene response to the ischemic investigator unaware of the treatment groups. Five fields change, real time PCR using a Lightcycler (Roche Diagper section were randomly selected and analyzed at a nostics, Mannheim, Germany) was performed with rat magnification of 4003. The number of capillaries was specific primers for VEGF and HIF-1a. Sequences of assessed from photomicrographs by computerized image primers used for rat VEGF were 59-CACCCACanalysis. GACAGAAGG-39 (sense) and 59-TCACAG-TGAACGCTCC-39 (antisense). Sequences of primers used for rat HIF-1a were 59-AGTCGGACAGCCTCAC-39 2.8. Myocardial perfusion detection (sense) and 59-TGCTGCCTTGTATGGGA-39 (antisense). The initial denaturation phase was 10 min at 95 8C At day 28 after transfection, animals were reanesthetized followed by an amplification phase as described below:
and their chests were opened. Radioactive microspheres denaturation at 95 8C for 10 s; annealing at 55 8C for 5 s;
(PerkinElmer Life Sciences, Inc., Boston, MA, USA), elongation at 72 8C for 15 s and for 30 cycles. approximately 700 000 in number, labeled with Cr, tion, fluorescence detection, and post-processing calculawere injected into the left ventricular cavity. The microtions were also performed using the Lightcycler apparatus.
spheres were allowed to circulate for 1 min. Then, the animals were euthanized, and the hearts were excised.
Infarct size determination
Tissue specimens from the left ventricle including the septum and right ventricular free wall were excised for Two weeks after myocardial infarction, rats were deeply measurement of radioactivity. The activities in the left anesthetized with pentobarbital and put to death by rapid ventricle were expressed per weight of heart tissue as a excision of the heart. The atria were trimmed from the ratio relative to the activity in the right ventricular free ventricles, and the right ventricle and left ventricle plus wall.
purchased for R&D Systems. The lower limit of detection of plasma VEGF was 5 pg / ml. The assay was performed in duplicate for each sample.
Statistical analysis
All results were expressed as mean6S.E.M. Statistical significance was evaluated by analysis of variance followed by Scheffe's procedure. A value of P,0.05 was considered to denote statistical significance.
Results

Evidence of transfection
To demonstrate the activity of reporter genes, X-Gal staining was performed 4 days after intramyocardial that were observed at the area near the infarct size, but not in the infarct area (Fig. 1) . This evidence showed that the 2.9. Measurement of plasma VEGF plasmids were delivered into the peri-infarct zone. The efficiency of gene transfer using b-galactosidase detection For the first six rats in each group, blood samples were was 3.660.5%. drawn from the left carotid artery at day 3 and from the right femoral artery at day 7 using a 23-gauge needle after 3.2. Human HIF-1a /VP16 and VEGF gene expression coronary ligation. After sampling 0.5 ml of blood, the left in myocardium carotid and right femoral arteries were ligated. The blood sample was stored at 4 8C for 30 min and then centrifuged
To confirm HIF-1a / VP16 and VEGF gene expression in at 3000 rev. / min for 15 min. Plasma was frozen at 280 8C the transfected rat myocardium, we analyzed the gene until assay of VEGF by a mouse VEGF ELISA kit, expression of transfected myocardium by detecting mRNA using RT-PCR. HIF-1a and VEGF mRNA were detected in the myocardium at days 1, 3, 7 and 14 after gene transfection (Fig. 2) . The mRNA of HIF-1a and VEGF could not be detected at day 28 after transfection. Neither HIF-1a nor VEGF mRNA was detected in distal tissues at days 3 and 7. Rat myocardium injected with pCMVb plasmid was consistently negative for HIF-1a and VEGF mRNA. To detect the endogenous gene response to the ischemic change, real time PCR using a Lightcycler (Roche Diagnostics, Mannheim, Germany) was performed with rat specific primers for VEGF and HIF-1a. The mRNA of endogenous VEGF at day 7 after infarction in the pHIF-1a / VP16, phVEGF , and pCMVb-treated 165 groups increased 2.4-, 4.2-, and 2.1-fold, respectively as compared to the normal rat without infarction. The mRNA of endogenous HIF-1a at 7 days after infarction in the pHIF-1a / VP16, phVEGF , and pCMVb-treated groups 165 increased 4.3-, 3.8-, and 2.8-fold, respectively as compared to the rat without infarction. Since the infarct size of the rats transfected with pCMVb was similar to that of rats transfected with saline only (data not shown), we used pCMVb-treated rats as the or phVEGF -treated group. The capillary density was 165 control. A total of 44 rats were studied for the determisimilar between the HIF-1a / VP16-treated and VEGFnation of infarct size with surgical mortality rates after treated groups. The capillary density of the control group coronary ligation and intramyocardial injection at 31% in (pCMVb) was significantly higher than that of the rat each group. Measurement of the infarct size of the left without infarction (data not shown). The capillary densities ventricle was performed in 31 hearts (four pHIF-1a / VP16 at day 14 after transfection were also significantly higher plus phVEGF -treated hearts, nine pHIF-1a / VP16-(P,0.05) in the pHIF-11a / VP16-treated group (650650 /   165  2  2 treated hearts, nine phVEGF -treated hearts and nine mm ) and the phVEGF -treated group (625650/mm ) 165 165 2 controls) at day 14 after transfection. Infarct size was than in the control (400675 / mm ). Grossly and microsignificantly smaller in the pHIF-1a / VP16-treated and scopically, no angioma formation was found in any phVEGF -treated groups than in the control group (2362 treated-animals or controls. The increased capillary density 165 and 2462% vs. 3764%, P,0.01 and P,0.05, respectivewas mainly limited to the area around the infarct area ly) as shown in Fig. 3 . The infarct size was similar (border zone). between the HIF-1a / VP16-treated and VEGF-treated groups. The infarction ratio (2063%) was further reduced 3.5. Measurement of regional blood flow by the combination of pHIF-1a / VP16 and phVEGF . 165 The infarct size was also significantly smaller in the Radioactive microspheres were used to measure relative pHIF-1a / VP16 and phVEGF -treated groups than in the blood flow in four hearts in each group. The right 165 control at day 7 after transfection (data not shown). ventricular free wall, which was noninfarcted in this model, served as the reference region. The weight of the 3.4. Capillary density left ventricle and the right ventricular free wall in each heart was about 1.0 and 0.2 g, respectively. In the rat Given that CD31 antibody specifically identifies capilwithout infarction, the radioactivity of the left ventricle laries, we used CD31 antibody to detect capillaries at 14 was 2-fold that of the right ventricular free wall. As shown and 28 days after transfection. Capillary densities observed in Fig. 5 , the regional blood flow ratio was significantly in the myocardium of the pHIF-1a / VP16-treated group higher in the treated rats than in the control group. There 2 (850650 / mm ) and the phVEGF -treated group was no significant difference in relative blood flow among 165 2 (850675 / mm ) were significantly higher (P,0.01) than the three treated groups.
2 that of the control (550675 / mm ) at day 28 after transfection, as shown in Fig. 4 . The capillary density in the group 3.6. HIF-1a /VP16 hybrid increases plasma VEGF level of combined pHIF-1a / VP16 and phVEGF was sig- the HIF-1a / VP16-treated group and the VEGF-treated tion activity but retains a high level of DNA binding that is group was significantly higher than that of the control equivalent in hypoxic and non-hypoxic cells [26] . This group at days 3 and 7 after coronary ligation. There was no result suggests that both the activation domain and the statistical difference in VEGF levels between the HIF-1a / protein region responsible for conferring destabilization VP16-treated group and the VEGF-treated group.
with normoxia are located between aa 390 and aa 826. By deleting this region of HIF-1a and replacing it with transactivation domain of herpes simplex virus VP16, the 4. Discussion HIF-1a / VP16 hybrid up-regulates exogenous VEGF expression in vitro and enhances angiogenesis in rabbit It has been reported that a deletion mutant of HIF-1a hindlimb ischemia [23] . In this study, we provide the first truncated at aa 390 exhibits severely reduced transactivademonstration that intramyocardial administration of HIF-Caution should be taken when interpreting our data. Since the results of histochemical staining with TTC were not validated by direct histologic examination of the affected tissues, we could not exclude the possibility that tissue staining properties were altered by therapy without prevention of tissue necrosis. Because capillary density would likely differ importantly in infarcted and noninfarcted regions, the amount of each tissue type within samples might significantly influence study outcome. Measurements of myocardial perfusion reflect blood flow to the entire left ventricle without distinction between flow to infarct and flow to surviving myocardium. The larger, better-perfused surviving portion of the myocardium is likely to dominate flow results. The observed flow increases in hearts treated with HIF-1a / VP16 or phVEGF 165 tissue was found after intramyocardial injection of 500 mg
165
The physiological study also demonstrated that regional of phVEGF in a rat model of myocardial infarction [27] . 165 myocardial perfusion and plasma level of VEGF, evidence We did not find any angioma formation in HIF-1a / VP16 for functional gene expression, were higher in the treated and VEGF-treated rats in this study: angioma formation group than in the control. However, the reduction in infarct may be dose-related. In this study, 50 mg of plasmid was size, the increase in capillary density, regional myocardial used. A recent study also demonstrated that high levels of blood flow, and plasma levels of VEGF in pHIF-1a / VP16 VEGF expression caused angioma formation in muscle and phVEGF were similar. Therefore, the efficacy of tissue, but low VEGF levels did not cause angioma 165 HIF-1a / VP16 hybrid and phVEGF as therapeutic formation [28] . Thus, intramyocardial injection of HIF-1a / 165 agents in enhancing angiogenesis in acute myocardial VP16 and phVEGF may be feasible in patients with 165 infarction is similar. Combined therapy with HIF-1a / acute myocardial infarction or with recent infarcts if a VP16 and VEGF induced more capillary formation than smaller dosage is administered. either therapy alone, although the infarct size could not be Administration of HIF-1a / VP16 hybrid via gene further reduced by the combined therapy. therapy may prove to be an effective treatment for 
